Search all medical codes
Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, methicillin resistant, amplified probe technique
CPT4 code
Name of the Procedure:
Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, methicillin-resistant, amplified probe technique (MRSA PCR test)
Summary
The MRSA PCR test is a diagnostic procedure used to detect the presence of methicillin-resistant Staphylococcus aureus (MRSA) in a patient. It involves analyzing a DNA or RNA sample to identify the presence of the MRSA bacteria using an amplified probe technique.
Purpose
- Medical Condition: This test addresses bacterial infections caused by MRSA.
- Goals/Outcomes: The goal is to rapidly and accurately identify the presence of MRSA to ensure timely and appropriate treatment.
Indications
- Symptoms: Persistent skin infections, chronic wounds, or unexplained symptoms of sepsis.
- Criteria: Patients with suspected MRSA infection or those in environments with high MRSA prevalence, such as hospitals or nursing homes.
Preparation
- Instructions: Generally, no specific preparation such as fasting is required.
- Diagnostics: Prior assessments may include a physical examination and review of clinical history.
Procedure Description
- Sample Collection: A sterile swab is used to collect a sample from the suspected infection site, often the nasal passages or a wound.
- Lab Analysis: The sample is sent to a laboratory where nucleic acid amplification tests (NAAT) are performed.
- Detection: An amplified probe technique is employed to identify MRSA DNA/RNA.
- Tools/Equipment: Sterile swabs, PCR machine, reagents for nucleic acid amplification.
- Anesthesia/Sedation: Not applicable as the test is non-invasive.
Duration
- The sample collection takes a few minutes.
- Laboratory analysis usually takes a few hours to a couple of days.
Setting
- Typically performed in outpatient settings such as doctor's offices, clinics, or hospitals.
Personnel
- Sample collection is often done by a nurse or technician.
- Lab analysis is conducted by clinical laboratory scientists.
Risks and Complications
- Common Risks: Minimal and generally limited to minor discomfort during sample collection.
- Rare Risks: False positives or negatives, though rare with proper technique.
Benefits
- Expected Benefits: Rapid and accurate identification of MRSA, leading to prompt and effective treatment.
- Timeframe: Results within hours to days.
Recovery
- Post-procedure Care: None required for the test itself.
- Recovery Time: Immediate; no restrictions post sample collection.
Alternatives
- Other Options: Traditional bacterial culture (takes longer, usually 48-72 hours for results).
- Pros and Cons: PCR test is faster and more sensitive than culture methods but may be more expensive.
Patient Experience
- During the Procedure: Brief discomfort during swab collection, similar to feeling during a nasal swab for COVID-19.
- After the Procedure: No downtime; results await.
Pain management or comfort measures are generally unnecessary due to the non-invasive nature of the procedure.